Infantile Spasms with Basal Ganglia MRI Hypersignal May Reveal Mitochondrial Disorder Due to T8993G MT DNA Mutation

Abstract

Purpose

To report three cases of infantile spasms (IS) with an abnormal magnetic resonance imaging signal in the basal ganglia (Leigh-like syndrome), due to T8993G mt DNA mutation.

Patients and Results

The first sign was, at the end of the first year of life, IS in one case and the combination of IS with behavior changes in the two other cases. Video EEG polygraphy demonstrated both spasms and hypsarrhythmia, but no other kind of seizures. Vigabatrin or steroids controlled the spasms with a follow-up of several years. All 3 patients had hyperlactatorrhachia (3.47 to 7 mmol/l). Axial hypotonia and dystonia appeared by the end of the first year of life. As in cases with the NARP mutation and onset later in life, neuropathy and retinopathy could also be demonstrated.

Discussion

Although it is well established that symptomatic IS with hypsarrhythmia mainly result from cortical lesions, this epileptic encephalopathy may also be generated by lesions in the basal ganglia without evidence of cortical damage. This finding suggests that West syndrome is likely to be caused by age-related dysfunction at any level of a cortico-putaminal loop of hyperexcitability.

Key words

Infantile spasms - West syndrome - mitochondriopathy - NARP mutation

References

• 1 Baumgartner M R, Hu C A, Almashanu S, Steel G, Obie C, Aral B. et al . Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase.  Hum Mol Genet. 2000;  9 2853-2858
• 2 Chugani H T, Shewmon D A, Sankar R, Chen B C, Phelps M E. Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomography.  Ann Neurol. 1992;  31 212-219
• 3 Dulac O, Chiron C, Robain O, Plouin P, Jambaque I I, Pinard J M. Infantile spasms: a pathophysiological hypothesis.  Semin Pediatr Neurol. 1994;  1 83-89
• 4 Dulac O, Chugani H T, Dalla Bernardina B. Infantile spasms and West syndrome. London; Saunders 1994
• 5 Fujii T, Hattori H, Higuchi Y, Tsuji M, Mitsuyoshi I. Phenotypic differences between T→C and T→G mutations at nt 8993 of mitochondrial DNA in Leigh syndrome.  Pediatr Neurol. 1998;  18 275-277
• 6 Gastaut H, Roger J, Soulayrol R, Pinsard N. Encéphalopathie myoclonique infantile avec hypsarrythmie (syndrome de West). Paris; Masson 1964
• 7 Hartzog P E, Cain B D. The aleu207→arg mutation in F1F0-ATP synthase from Escherichia coli. A model for human mitochondrial disease.  J Biol Chem. 1993;  268 12250-12252
• 8 Holt I J, Harding A E, Petty R K, Morgan-Hughes J A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.  Am J Hum Genet. 1990;  46 428-433
• 9 Hrachovy R A, Frost Jr J D, Kellaway P. Sleep characteristics in infantile spasms.  Neurology. 1981;  31 688-693
• 10 Lortie A, Chiron C, Mumford J, Dulac O. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin.  Neurology. 1993;  43 S24-S27
• 11 Lyon G, Adams R, Kolodny E. Neurology of Hereditary Metabolic Diseases of Children. 2nd ed. New York; Mc Graw Hill 1996
• 12 Malafosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R. Idiopathic Generalised Epilepsies: Clinical, Experimental and Genetic Aspects. London; Libbey 1994
• 13 Mikaeloff Y, Plouin P, Dhondt J L, Ponsot G, Dulac O. Clinical and EEG video-polygraphic features of epileptic spasms in a child with dihydropteridine reductase deficiency. Efficiency of hydrocortisone.  Epileptic Disord. 2000;  2 213-217
• 14 Obeso J A, Lang A E, Rothwell J C, Marsden C D. Postanoxic symptomatic oscillatory myoclonus.  Neurology. 1983;  33 240-243
• 15 Rahman S, Blok R B, Dahl H H, Danks D M, Kirby D M, Chow C W. et al . Leigh syndrome: clinical features and biochemical and DNA abnormalities.  Ann Neurol. 1996;  39 343-351
• 16 Robinson B H. MtDNA and nuclear mutations affecting oxidative phosphorylation: correlating severity of clinical defect with extent of bioenergetic compromise.  J Bioenerg Biomembr. 1994;  26 311-316
• 17 Sakuta R, Goto Y, Horai S, Ogino T, Yoshinaga H, Ohtahara S. et al . Mitochondrial DNA mutation and Leigh's syndrome.  Ann Neurol. 1992;  32 597-598
• 18 Santorelli F M, Shanske S, Jain K D, Tick D, Schon E A, DiMauro S. A T → C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome.  Neurology. 1994;  44 972-974
• 19 Santorelli F M, Shanske S, Macaya A, DeVivo D C, DiMauro S. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome.  Ann Neurol. 1993;  34 827-834
• 20 Shoffner J M, Fernhoff P M, Krawiecki N S, Caplan D B, Holt P J, Koontz D A. et al . Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation.  Neurology. 1992;  42 2168-2174
• 21 Tatuch Y, Christodoulou J, Feigenbaum A, Clarke J T, Wherret J, Smith C. et al . Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.  Am J Hum Genet. 1992;  50 852-858
• 22 Tatuch Y, Pagon R A, Vlcek B, Roberts R, Korson M, Robinson B H. The 8993 mtDNA mutation: heteroplasmy and clinical presentation in three families.  Eur J Hum Genet. 1994;  2 35-43
• 23 Tsao C Y, Luquette M, Rusin J A, Herr G M, Kien C L, Morrow III G. Leigh syndrome, cytochrome C oxidase deficiency and hypsarrhythmia with infantile spasms.  Clin Electroencephalogr. 1997;  28 214-217
• 24 Yoshinaga H, Ogino T, Ohtahara S, Sakuta R, Nonaka I, Horai S. A T-to-G mutation at nucleotide pair 8993 in mitochondrial DNA in a patient with Leigh's syndrome.  J Child Neurol. 1993;  8 129-133